Device
CureSight
CureSight is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed250%
unknown250%
Recent Activity
0 active trials
Showing 4 of 4
unknownnot_applicable
Treating Amblyopia With CureSight
NCT06165705
completednot_applicable
CURESIGHT BINOCULAR AMBLYOPIA TREATMENT STUDY
NCT04785690
completednot_applicable
Eye-tracking Based Amblyopia Training
NCT05078099
unknownnot_applicable
Treatment for Amblyopia Under Binocular Conditions Versus the Standard of Care, Monocular Deprivation Treatment
NCT05185076
Clinical Trials (4)
Showing 4 of 4 trials
NCT06165705Not Applicable
Treating Amblyopia With CureSight
NCT04785690Not Applicable
CURESIGHT BINOCULAR AMBLYOPIA TREATMENT STUDY
NCT05078099Not Applicable
Eye-tracking Based Amblyopia Training
NCT05185076Not Applicable
Treatment for Amblyopia Under Binocular Conditions Versus the Standard of Care, Monocular Deprivation Treatment
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4